A Phase 1 Study of XL019 in Adults With Polycythemia Vera
NCT00595829
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class
Conditions
Polycythemia Vera
Interventions
DRUG:
XL019
Sponsor
Exelixis